Controls to validate plasma samples for cell free DNA quantification

Clinica Chimica Acta

Volumn 446, Issue , 2015, Pages 141-146

  Pallisgaard, Niels ^a   Spindler, Karen Lise Garm ^a,b   Andersen, Rikke Fredslund ^a   Brandslund, Ivan ^a   Jakobsen, Anders ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CfDNA; Lymphocyte DNA; QPCR; Quality control

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG; CPP1 PROTEIN, GLYCINE MAX; DNA BINDING PROTEIN;

ALLELE; ANALYTICAL ERROR; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DNA DETERMINATION; DNA FRAGMENTATION; FOLLOW UP; GENE REARRANGEMENT; IMMUNOGLOBULIN GENE; MEASUREMENT ACCURACY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURIFICATION; RELIABILITY; RISK FACTOR; STANDARDIZATION; TOTAL QUALITY MANAGEMENT; VALIDATION PROCESS; BLOOD; CYTOLOGY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; STANDARD; STANDARDS;

ALLELES; B-LYMPHOCYTES; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; POLYMERASE CHAIN REACTION; REFERENCE STANDARDS;

EID: 84938486899     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.04.015     Document Type: Article

References (19)

1. MANDEL P., METAIS P. Les acides nucleique du plasma sanguin chez l'homme. C R Seances Soc Biol Fil 1948, 142:241-243.
2. Spindler K.L., Appelt A.L., Pallisgaard N., Andersen R.F., Brandslund I., Jakobsen A. Cell-free DNA in healthy individuals, non-cancerous disease and strong prognostic value in colorectal cancer. Int J Cancer 2014, 135:2984-2991.
3. Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hersch R.D., et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001, 61:1659-1665.
4. Stroun M., Lyautey J., Lederrey C., Olson-Sand A., Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001, 313:139-142.
5. de Sousa M.V., Madsen K., Fukui R., Santos A., da Silva M.E. Carbohydrate supplementation delays DNA damage in elite runners during intensive microcycle training. Eur J Appl Physiol 2012, 112:493-500.
6. Bettegowda C., Sausen M., Leary R.J., Kinde I., Wang Y., Agrawal N., et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 2014, 6:224ra24.
7. Dawson S.J., Tsui D.W., Murtaza M., Biggs H., Rueda O.M., Chin S.F., et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013, 368:1199-1209.
8. Esposito A., Bardelli A., Criscitiello C., Colombo N., Gelao L., Fumagalli L., et al. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities. Cancer Treat Rev 2014, 40:648-655.
9. Gonzalez-Masia J.A., Garcia-Olmo D., Garcia-Olmo D.C. Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology. Oncol. Targets Ther. 2013, 6:819-832.
10. El Messaoudi S., Rolet F., Mouliere F., Thierry A.R. Circulating cell free DNA: preanalytical considerations. Clin Chim Acta 2013, 424:222-230.
11. Diehl F., Li M., He Y., Kinzler K.W., Vogelstein B., Dressman D. BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions. Nat Methods 2006, 3:551-559.
12. Taly V., Pekin D., El A.A., Laurent-Puig P. Detecting biomarkers with microdroplet technology. Trends Mol Med 2012, 18:405-416.
13. van Dongen J.J., Langerak A.W., Bruggemann M., Evans P.A., Hummel M., Lavender F.L., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003, 17:2257-2317.
14. Cvitanich C., Pallisgaard N., Nielsen K.A., Hansen A.C., Larsen K., Pihakaski-Maunsbach K., et al. CPP1, a DNA-binding protein involved in the expression of a soybean leghemoglobin c3 gene. Proc Natl Acad Sci U S A 2000, 97:8163-8168.
15. Jung K., Fleischhacker M., Rabien A. Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature. Clin Chim Acta 2010, 411:1611-1624.
16. van der Vaart M., Pretorius P.J. Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?. Clin Biochem 2010, 43:26-36.
17. Espy M.J., Uhl J.R., Sloan L.M., Buckwalter S.P., Jones M.F., Vetter E.A., et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006, 19:165-256.
18. Fridman W.H., Pages F., Sautes-Fridman C., Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012, 12:298-306.
19. Linnemann C., Mezzadra R., Schumacher T.N. TCR repertoires of intratumoral T-cell subsets. Immunol Rev 2014, 257:72-82.